Navigation Links
Black Cohosh Does Not Treat Hot Flashes

The effectiveness of Black cohosh, a drug used to treat post menopausal women was checked by a federally funded study// and was proved to be no better than a dummy pill.

There was a marked decrease in the severity and frequency of symptoms by 30% in a year’s span irrespective of the fact whether women took Black cohosh or a placebo.

Black cohosh, a perennial herb member of the buttercup family, is the most widely used herbal remedy for hot flashes.

The Herbal Alternatives for Menopause Trial (HALT), was a one-year, double-blind, randomized, and controlled trial comparing the effects of three formulations of black cohosh with hormone therapy and placebo for relief of hot flashes and night sweats.

Researchers assigned 351 women aged 45 to 55 to one of five groups:

? black cohosh alone

? multi-herb pill with black cohosh and nine other ingredients

? the multi-herb pill plus counseling to increase intake of dietary soy

? hormone therapy (estrogen with or without progestin)

? placebo (dummy pill)

"About 80 percent of women who go through menopause experience hot flashes," said Katherine M. Newton, PhD, Associate Director for Research at Group Health in Seattle, and lead author of the study.”

"Many women are looking for alternatives to hormone therapy which is the most proven remedy for hot flashes, and many are using alternative medicines," Newton said. "The most commonly used alternative is black cohosh. But we found that black cohosh was no better than placebo in treating hot flashes."

The study found that hormone therapy gave women most relief, reducing symptoms by an average of about four symptoms per day more than placebo.

Hormone therapy was included in the HALT study because it is a well-known and proven treatment to reduce menopausal symptoms. The HALT study began in 2001 and stopped the hormone therapy arm of the trial after the Women's H ealth Initiative found in 2002 that estrogen plus progestin increased risk for breast cancer, heart attacks, strokes and blood clots.

"Whether or not the black cohosh findings are bad news for women depends on how you look at it," said Newton. "It's disappointing that we didn't find black cohosh to be an effective remedy.

On the other hand, thousands of women, probably hundreds of thousands of women, buy products that contain black cohosh to help relieve their menopausal symptoms. Our study indicates that black cohosh is not a promising remedy to treat their hot flashes.

The HALT study was funded by the National Institute on Aging and the National Center for Complementary and Alternative Medicine. It is the most definitive study yet of the effects of black cohosh. Previous studies have been small, short-term studies that were inconclusive.

The study, "Treatment of Vasomotor Symptoms of Menopause with Black Cohosh, Multibotanicals, Soy, Hormone Therapy, or Placebo," and an accompanying editorial, " A Randomized Trial of Alternative Medicines for Vasomotor Symptoms of Menopause," is published in the Dec. 19, 2006, issue of Annals of Internal Medicine.

Editorial writers say the study is a "well-designed, adequately powered RCT that makes an important contribution, albeit one that will disappoint women who have been hoping for an effective, safe alternative to estrogen."

The good news, the editorial writers say, is that women in the placebo group experienced about a 30 percent reduction in severity and frequency of symptoms during the 12-month follow-up period.

This means that many women will probably have fewer symptoms within six to 12 months without any treatment at all.

Source-Eurekalert
KO
'"/>




Related medicine news :

1. AIDS toll set to exceed Black Death
2. Black tea said to lower cholesterol
3. Women and Black Patients have less chances to survive a Heart Attack
4. Blacks decline Lung cancer surgery
5. Fewer Blacks Undergo Lung Cancer Surgery
6. Home Remedies More Used By Blacks And Native Americans
7. Black Actor Confesses Sex Cult Past
8. Malfunction Of Key Growth Factor Increases Mortality Rate From Pulmonary Fibrosis In Blacks
9. HRT elevates breast cancer risk in Black women.
10. The Naked Truth about AIDS. Advertisements Drive The Point Home in Black And White!
11. Blacks and East Asians Prone To Side Effects of Cardiovascular Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/22/2017)... , ... February 22, 2017 , ... ... and the number of African American/Black students who want to become physicians. PMF ... pursue their careers as physicians in the Oakland/San Francisco Northern California, Bay Area. ...
(Date:2/21/2017)... ... February 21, 2017 , ... Hanna Boys Center ... will be the keynote speaker at its second Professional Networking Breakfast on March ... which develops comprehensive strategies to create and expand opportunities for boys and young ...
(Date:2/21/2017)... ... February 21, 2017 , ... Ray Insurance Agencies, a Dallas area ... Tarrant County, is embarking on a six month charity event aimed at raising local ... , Cancer is one of the deadliest diseases in America; more than 7.5 million ...
(Date:2/21/2017)... Michigan (PRWEB) , ... February 21, 2017 , ... ... to the United States during Black History Month (officially African American History ... to many fields of American society of a diverse race of people, but ...
(Date:2/21/2017)... CA (PRWEB) , ... February 21, 2017 , ... A ... data on gastric balloons for weight loss. It found that the treatments have led ... of obese patients, when compared to unassisted efforts. It also noted very few problematic ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... , Feb. 22, 2017 Henry ... an exclusive distribution agreement with Rijuven, which develops ... diagnostic device to medical practitioners. ... electrocardiogram (ECG) and heart sound signals, transmits real-time ... and offers cloud-based analysis to help physicians provide ...
(Date:2/22/2017)... -- Bioness, Inc., the leading provider of cutting edge, clinically ... successful StimRouter Neuromodulation System implantations in Europe ... Netherlands ), South Victoria ... Kliniek Park Leopold Chirec ( Brussels, Belgium ... further support clinicians across the continent who are looking ...
(Date:2/22/2017)... , Feb. 22, 2017 Oncternal Therapeutics, ... for both rare and common malignancies, today announced ... financing. The company intends to use the proceeds ... TK216, and to advance preclinical development of a ... Cirmtuzumab is a first-in-class anti-ROR1 monoclonal antibody being ...
Breaking Medicine Technology: